| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
X4 Pharmaceuticals, Inc (XFOR) has 7 insiders with recent SEC Form 4 filings, including 17 buys and 0 sells. XFOR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 2.33M | $9.60M | - | |
| Pres | 2.33M | $9.60M | - | |
| CFO | 1.55M | $6.40M | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2017 | Svlsf V, LLC | 10% Owner | Buy | 500,000 | $10.00 | $5,000,000.00 | +15.5% | |
| Nov 20, 2017 | Ross Michael Jay | Director, 10% Owner | Buy | 500,000 | $10.00 | $5,000,000.00 | +15.5% | |
| Nov 20, 2017 | Nessi Claudio | Director | Buy | 300,000 | $10.00 | $3,000,000.00 | +52.9% | |
| Nov 20, 2017 | McGuire Terrance | Director, 10% Owner | Buy | 500,000 | $10.00 | $5,000,000.00 | +36.5% | |
| Nov 20, 2017 | Gordon Carl L74 | Director, 10% Owner | Buy | 500,000 | $10.00 | $5,000,000.00 | +36.5% | |
| Nov 20, 2017 | Embl Technology Fund II Gmbh & Co. Kg | 10% Owner | Buy | 20,000 | $10.00 | $200,000.00 | +5.7% | |
| Nov 20, 2017 | Neomed Innovation V L.P. | 10% Owner | Buy | 300,000 | $10.00 | $3,000,000.00 | +52.9% | |
| Nov 20, 2017 | Gerngross Tillman U. | Director | Buy | 200,000 | $10.00 | $2,000,000.00 | +103.7% | |
| Nov 20, 2017 | Polaris Venture Management Co. V, L.l.c. | 10% Owner | Buy | 500,000 | $10.00 | $5,000,000.00 | +36.5% |